Immunocore Holdings PLC Sponsored ADR ( IMCR - Free Report ) closed the last trading session at $29.06, gaining 2.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $62.29 indicates an 114.4% upside potential.